Skip to main content

Advertisement

SpringerLink
Log in

Depression in the medically Ill: Diagnostic and therapeutic implications

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Depression and medical comorbidities lead to increased morbidity and mortality and have been associated with higher health care costs. Depressive disorders can adversely impact the course of medical illnesses, whereas medical illnesses can serve as a risk factor for future depressive disorders. This interplay has spurred some interesting exploratory research to understand the common pathophysiology and neurobiologic substrates that may explain the bidirectional relationship between the two disorders. There is a paucity of well-designed, randomized, controlled trials to address some of the treatment-related prognostic issues in this population. However, more recent studies have focused on diagnostic and treatment implications with various available pharmacologic and psychotherapeutic modalities. Early identification and appropriate treatment of depression in the medically ill can positively influence medical outcomes and quality of life. Collaborative care models integrating mental health and primary care providers, combined with patient preference, are found to be cost-effective and may result in better response to depression treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Insel TR, Charney DS: Research on major depression: strategies and priorities. JAMA 2003, 289:3167–3168.

    Article  PubMed  Google Scholar 

  2. Michaud CM, Murray CJ, Bloom BR: Burden of disease—implications for future research. JAMA 2001, 285:535–539.

    Article  PubMed  CAS  Google Scholar 

  3. Wells KB, Golding JM, Burnam MA: Psychiatric disorder in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988, 145:976–981.

    PubMed  CAS  Google Scholar 

  4. Druss BG, Marcus SC, Olfson M, et al.: Comparing the national economic burden of five chronic conditions. Health Aff 2001, 20:233–241.

    Article  CAS  Google Scholar 

  5. Wang PS, Patrick A, Avorn J, et al.: The costs and benefits of enhanced depression care to employers. Arch Gen Psychiatry 2006, 63:1345–1353.

    Article  PubMed  Google Scholar 

  6. Young AS, Klap R, Sherbourne CD, Wells KB: The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58:55–61.

    Article  PubMed  CAS  Google Scholar 

  7. Thase ME: The clinical, psychosocial, and pharmacoeconomic ramifications of remission. Am J Manag Care 2001, 7(11 Suppl):S377–S385.

    PubMed  CAS  Google Scholar 

  8. Katon WJ: Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003, 54:216–226.

    Article  PubMed  Google Scholar 

  9. Thielke S, Vannoy S, Unützer J: Integrating mental health and primary care. Prim Care 2007, 34:571–592, vii.

    PubMed  Google Scholar 

  10. Rush AJ: STAR*D: what have we learned? Am J Psychiatry 2007, 164:201–204.

    Article  PubMed  Google Scholar 

  11. Yates WR, Mitchell J, Rush AJ, et al.: Clinical features of depression in outpatients with and without co-occurring general medical conditions in STAR*D: confirmatory analysis. Prim Care Companion J Clin Psychiatry 2007, 9:7–15.

    PubMed  Google Scholar 

  12. Hussain MM, Rush AJ, Trivedi MH, et al.: Pain in depression: STAR*D study findings. J Psychosom Res 2007, 63:113–122.

    Article  Google Scholar 

  13. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998, 55:580–592.

    Article  PubMed  CAS  Google Scholar 

  14. Rudisch B, Nemeroff CB: Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 2003, 54:227–240.

    Article  PubMed  Google Scholar 

  15. Jiang W, Alexander J, Christopher E, et al.: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161:1849–1856.

    Article  PubMed  CAS  Google Scholar 

  16. Lespérance F, Frasure-Smith N: Depression in patients with cardiac disease: a practical review. J Psychosom Res 2000, 48:379–391.

    Article  PubMed  Google Scholar 

  17. Frasure-Smith N, Lespérance F, Juneau M, et al.: Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med 1999, 61:26–37.

    PubMed  CAS  Google Scholar 

  18. Connerney I, Shapiro PA, McLaughlin JS, et al.: Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 2001, 358:1766–1771.

    Article  PubMed  CAS  Google Scholar 

  19. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al.: The nature and course of depression following myocardial infarction. Arch Intern Med 1989, 149:1785–1789.

    Article  PubMed  CAS  Google Scholar 

  20. Fraguas R, Iosifescu DV, Alpert J, et al.: Major depressive disorder and comorbid cardiac disease: is there a depressive subtype with greater cardiovascular morbidity? Results from the STAR*D study. Psychosomatics 2007, 48:418–425.

    Article  PubMed  Google Scholar 

  21. Joynt KE, Whellan DJ, O’Connor CM: Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003, 54:248–261.

    Article  PubMed  Google Scholar 

  22. Roose SP: Treatment of depression in patients with heart disease. Biol Psychiatry 2003, 54:262–268.

    Article  PubMed  CAS  Google Scholar 

  23. Glassman AH, Preud’homme XA: Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry 1993, 54:16–22.

    PubMed  Google Scholar 

  24. Lespérance F, Frasure-Smith N, Koszycki D, et al.: Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA 2007, 297:367–379.

    Article  PubMed  Google Scholar 

  25. Glassman AH, O’Connor CM, Califf RM, et al.: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701–709.

    Article  PubMed  CAS  Google Scholar 

  26. Glassman AH, Bigger JT, Gaffney M, et al.: Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006, 63:283–288.

    Article  PubMed  Google Scholar 

  27. Cowan MJ, Freedland KE, Burg MM, et al.: Predictors of treatment response for depression and inadequate social support—the ENRICHD randomized clinical trial. Psychother Psychosom 2008, 77:27–37.

    Article  PubMed  Google Scholar 

  28. Evans DL, Charney DS, Lewis L, et al.: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005, 58:175–189.

    Article  PubMed  Google Scholar 

  29. Robinson RG: Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003, 54:376–387.

    Article  PubMed  Google Scholar 

  30. Morris PL, Robinson RG, Andrzejewski P, et al.: Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993, 150:124–129.

    PubMed  CAS  Google Scholar 

  31. Narushima K, Kosier JT, Robinson RG: A reappraisal of poststroke depression, intra-and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci 2003, 15:422–430.

    PubMed  CAS  Google Scholar 

  32. Musselman DL, Marzec UM, Manatunga A, et al.: Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000, 7:875–882.

    Article  Google Scholar 

  33. Chen Y, Guo JJ, Zhan S, Patel NC: Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Ann Pharmacother 2006, 40:2115–2122.

    Article  PubMed  CAS  Google Scholar 

  34. Williams LS, Kroenke K, Bakas T, et al.: Care management of poststroke depression: a randomized, controlled trial. Stroke 2007, 38:998–1003.

    Article  PubMed  Google Scholar 

  35. McDonald WM, Richard IH, DeLong MR: Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry 2003, 54:363–375.

    Article  PubMed  Google Scholar 

  36. Lyketsos CG, DelCampo L, Steinberg M, et al.: Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Arch Gen Psychiatry 2003, 60:737–746.

    Article  PubMed  CAS  Google Scholar 

  37. Kanner AM: Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003, 54:388–398.

    Article  PubMed  Google Scholar 

  38. Raison CL, Miller AH: Depression in cancer: new developments regarding diagnosis and treatment. Biol Psychiatry 2003, 54:283–294.

    Article  PubMed  Google Scholar 

  39. Penninx BW, Guralnik JM, Pahor M, et al.: Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 1998, 90:1888–1893.

    Article  PubMed  CAS  Google Scholar 

  40. Stommel M, Given BA, Given CW: Depression and functional status as predictors of death among cancer patients. Cancer 2002, 94:2719–2727.

    Article  PubMed  Google Scholar 

  41. Newport DJ, Nemeroff CB: Assessment and treatment of depression in the cancer patient. J Psychosom Res 1998, 45:215–237.

    Article  PubMed  CAS  Google Scholar 

  42. Fawzy FI, Canada AL, Fawzy NW: Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry 2003, 60:100–103.

    Article  PubMed  Google Scholar 

  43. Theobald DE, Kirsh KL, Holtsclaw E, et al.: An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. J Pain Symptom Manage 2002, 23:442–447.

    Article  PubMed  CAS  Google Scholar 

  44. Evans DL, McCartney CF, Haggerty JJ Jr, et al.: Treatment of depression in cancer patients is associated with better life adaptation: a pilot study. Psychosom Med 1988, 50:73–76.

    PubMed  CAS  Google Scholar 

  45. Holland JC, Romano SJ, Heiligenstein JH, et al.: A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 1998, 7:291–300.

    Article  PubMed  CAS  Google Scholar 

  46. Musselman DL, Lawson DH, Gumnick JF, et al.: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 2001, 344:961–966.

    Article  PubMed  CAS  Google Scholar 

  47. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069–1078.

    Article  PubMed  CAS  Google Scholar 

  48. de Groot M, Anderson R, Freedland KE, et al.: Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619–630.

    PubMed  Google Scholar 

  49. Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000, 160:3278–3285.

    Article  PubMed  CAS  Google Scholar 

  50. Lustman PJ, Anderson RJ, Freedland KE, et al.: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:934–942.

    Article  PubMed  CAS  Google Scholar 

  51. Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003, 54:317–329.

    Article  PubMed  Google Scholar 

  52. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB: The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003, 25:246–252.

    Article  PubMed  Google Scholar 

  53. Lustman PJ, Clouse RE, Freedland KE: Management of major depression in adults with diabetes: implications of recent clinical trials. Semin Clin Neuropsychiatry 1998, 3:102–114.

    PubMed  Google Scholar 

  54. Ickovics JR, Hamburger ME, Vlahov D, et al.: Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001, 285:1466–1474.

    Article  PubMed  CAS  Google Scholar 

  55. Leserman J, Petitto JM, Gu H, et al.: Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med 2002, 32:1059–1073.

    Article  PubMed  CAS  Google Scholar 

  56. Perkins DO, Stern RA, Golden RN, et al.: Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry 1994, 151:233–236.

    PubMed  CAS  Google Scholar 

  57. Morrison MF, Petitto JM, Ten Have T, et al.: Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry 2002, 159:789–796.

    Article  PubMed  Google Scholar 

  58. Perretta P, Akiskal HS, Nisita C, et al.: The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV-patients. J Affect Disord 1998, 50:215–224.

    Article  PubMed  CAS  Google Scholar 

  59. Gorman JM, Kertzner R, Cooper T, et al.: Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. Am J Psychiatry 1991, 148:41–45.

    PubMed  CAS  Google Scholar 

  60. Evans DL, Ten Have TR, Douglas SD, et al.: Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry 2002, 159:1752–1759.

    Article  PubMed  Google Scholar 

  61. Cole SW, Korin YD, Fahey JL, Zack JA: Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 1998, 161:610–616.

    PubMed  CAS  Google Scholar 

  62. Rabkin JG, Wagner GJ, Rabkin R: Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. Am J Psychiatry 1999, 156:101–107.

    PubMed  CAS  Google Scholar 

  63. Wagner GJ, Rabkin JG, Rabkin R: A comparative analysis of standard and alternative antidepressants in the treatment of human immunodeficiency virus patients. Compr Psychiatry 1996, 37:402–408.

    Article  PubMed  CAS  Google Scholar 

  64. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS: Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997, 13:116–137.

    Article  PubMed  CAS  Google Scholar 

  65. Magni G, Rigatti-Luchini S, Fracca F, Merskey H: Suicidality in chronic abdominal pain: an analysis of the Hispanic Health and Nutrition Examination Survey (HHANES). Pain 1998, 76:137–144.

    Article  PubMed  CAS  Google Scholar 

  66. Lynch ME: Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 2001, 26:30–36.

    PubMed  CAS  Google Scholar 

  67. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS: Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med 2000, 1:310–316.

    Article  PubMed  CAS  Google Scholar 

  68. Dalton JA, Keefe FJ, Carlson J, Youngblood R: Tailoring cognitive-behavioral treatment for cancer pain. Pain Manag Nurs 2004, 5:3–18.

    Article  PubMed  Google Scholar 

  69. Williams JW Jr, Noël PH, Cordes JA, et al.: Is this patient clinically depressed? JAMA 2002, 287:1160–1170.

    Article  PubMed  Google Scholar 

  70. Katon W, Von Korff M, Lin E, et al.: Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995, 273:1026–1031.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Office of Biological Research, Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Suite 301, 15 Medical Park, 3555 Harden Street Extension, Columbia, SC, 29203, USA

    Meera Narasimhan

Authors
  1. Meera Narasimhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey D. Raynor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashley Blackmon Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meera Narasimhan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Narasimhan, M., Raynor, J.D. & Jones, A.B. Depression in the medically Ill: Diagnostic and therapeutic implications. Curr Psychiatry Rep 10, 272–279 (2008). https://doi.org/10.1007/s11920-008-0044-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-008-0044-z

Keywords

Search

Navigation